Authors

While the July/August issue shines light on minimally invasive devices like lasers, injectables and PRP as preventive aesthetics rises for younger generations, it also has a particular focus on men in aesthetics.

Men are changing the landscape of aesthetic medicine as it continues to evolve. This transformation is not just cultural but also clinical, necessitating a reassessment of both practice and theory.

This upcoming webinar with Podium on July 7, "5 Proven Strategies to Keep Your Aesthetic Practice Fully Booked and Thriving," offers a practical, results-driven solution for practices ready to elevate their operations.

While there has been considerable recent private investment activity across over 30 sponsor platforms with a focus on the sector, only 10% of the Medspa practice market has been consolidated to date, indicating plenty of opportunity for continued investment to scale business operations.

In the world of aesthetics, trends evolve, but few have transformed the industry as rapidly as the rise of the "20-year-old facelift."

In the U.S., 9,500 people are diagnosed with skin cancer every day. Sun protection is non-negotiable in skincare, but all SPF is not created equal.

In a space like aesthetics, inclusivity and diversity is critical. Inclusivity not only entails cognizance of different skin texture and tones depending on race or gender, but also finance options.

It is becoming increasingly important for practices to create packages and treatment plans that reflect the market and consumer budgets.

When practitioners truly understand the biology of different skin types and the cultural context behind each patient’s goals, the care becomes more accurate, more respectful and ultimately more effective.

Men are increasingly seeking out procedures like Botox, a trend that's been humorously dubbed “brotox.”

My industry is once again witnessing a shift in more of a natural result. Exosomes can help with that. They are revolutionary.

GLP-1 medications are reshaping aesthetics by introducing new patient demographics and treatment demands.

The aesthetics industry is at a pivotal point, as Gen Z, ages 15-28, emerges as a significant consumer group.

Neurotoxins, long recognized for their ability to smooth dynamic wrinkles, are now emerging as a groundbreaking treatment for inflammatory skin conditions.

The aesthetics industry has always been long sought after for anti-aging procedures and treatments but Gen Z are showing a demand in preventive aesthetics that diminish signs of aging before they occur.

From AI-assisted procedures to bio-engineered materials, emerging technologies are reshaping how surgeons approach reconstructive and cosmetic procedures.

As patients increasingly seek a full spectrum of care, this shift creates an opportunity for practices to incorporate retail as a core revenue driver.

The medspa industry is experiencing a surge in M&A activity, driven by increased consumer demand for non-invasive cosmetic procedures, the entry of private equity firms and the desire of existing owners to exit the market.

Some medspa owners with established and successful business models are looking to expand their reach through franchising opportunities. This can mean being confronted with a fork-in-the-road decision: franchise or independent.

The world of cosmetic surgery is evolving faster than ever, and the trends shaping the industry are both fascinating and insightful. Subtlety and sophistication are now the name of the game.

The baby facelift, an evolution of the mini facelift, directly addresses the growing demand for minimally invasive solutions that deliver real results where other approaches often fall short. Dr. Shah delves into his predictions and insights.

Feature Articles, Content Collaboration, Columns, Face & Body Education

Industry Trends and News, Product Launches, Editorial Submissions, Social Media

Feature Articles, Columns, Partnership Opportunities, Spa Snapshot, Face & Body Education

Executive Director, Strategic Product Development & Innovation: Consumer Goods & Skincare; AbbVie